1 Min Read
* Orbimed Advisors LLC cuts stake in Roka Bioscience to 10.24 percent as of Oct 3 from a stake of 13.86 percent as of Sept 28 - SEC filing Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.